AbbVie Partners With Valkai To Advance AI-powered Clinical Research

WASHINGTON (dpa-AFX) - AbbVie, Inc. (ABBV), a pharmaceutical company, announced a partnership with Valkai, a life sciences artificial intelligence platform, to enhance its AI infrastructure and accelerate scientific innovation.Through the partnership, AbbVie will deploy purpose-built AI capabilitie…